Zobrazeno 1 - 10 of 423 pro vyhledávání: '"W, Boucher"'
1
Akademický článek
Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learning
Autor: Shira Doron, Robin R. Ingalls, Anne Beauchamp, Jesse S. Boehm, Helen W. Boucher, Linda H. Chow, Linda Corridan, Katey Goehringer, Doug Golenbock, Liz Larsen, David Lussier, Marcia Testa, Andrea Ciaranello
Publikováno v: Cell Reports Medicine, Vol 2, Iss 11, Pp 100452- (2021)
Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in K–12 schools was rare during in 2020–2021; few studies included Centers for Disease Control and Prevention (CDC)-recommended screening of asymptomatic individua
Externí odkaz: https://doaj.org/article/90a57780293340a2b9be6f4eb595aacd
Zobrazit plný text záznamu
2
Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs
Autor: Tori Kinamon, Ramya Gopinath, Ursula Waack, Mark Needles, Daniel Rubin, Deborah Collyar, Sarah B Doernberg, Scott Evans, Toshimitsu Hamasaki, Thomas L Holland, Jessica Howard-Anderson, Henry Chambers, Vance G Fowler, Sumati Nambiar, Peter Kim, Helen W Boucher
Publikováno v: Clinical Infectious Diseases.
Background Desirability of outcome ranking (DOOR) is a novel approach to clinical trial design that incorporates safety and efficacy assessments into an ordinal ranking system to evaluate overall outcomes of clinical trial participants. Here, we deri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a76a40f39134e5021564219c5f4cae72
https://doi.org/10.1093/cid/ciad239
Zobrazit plný text záznamu
4
Enhancer-promoter interactions are reconfigured through the formation of long-range multiway chromatin hubs as mouse ES cells exit pluripotency
Autor: D. Lando, X. Ma, Y. Cao, A. Jartseva, T. J. Stevens, W. Boucher, N. Reynolds, B. Montibus, D. Hall, A Lackner, R. Ragheb, M Leeb, B. D. Hendrich, E. D. Laue
SummaryEnhancers are genomic DNA sequences that bind transcription factors, chromatin regulators and non-coding transcripts to modulate the expression of target genes. They have been found to act from different locations relative to a gene and to mod
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f10c9ecb373976e6a24a0b6a64e13a33
https://doi.org/10.1101/2023.02.08.527615
Zobrazit plný text záznamu
5
Characterization of a Novel Pathogen in Immunocompromised Patients: Elizabethkingia anophelis—Exploring the Scope of Resistance to Contemporary Antimicrobial Agents and β-lactamase Inhibitors
Autor: Mohamad Yasmin, Laura J Rojas, Steven H Marshall, Andrea M Hujer, Anna Cmolik, Emma Marshall, Helen W Boucher, Alejandro J Vila, Maxime Soldevila, Seydina M Diene, Jean-Marc Rolain, Robert A Bonomo
Publikováno v: Open Forum Infect Dis
Open Forum Infectious Diseases
Open Forum Infectious Diseases, 2023, 10 (2), pp.ofad014. ⟨10.1093/ofid/ofad014⟩
BackgroundElizabethkingia anophelis is an emerging Gram-negative nonlactose fermenter in the health care setting, where it causes life-threatening infections in immunocompromised patients. We aimed to characterize the molecular mechanisms of antimicr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9e88a69621f9d08160de3f0eba0f9f
https://europepmc.org/articles/PMC9938519/
Zobrazit plný text záznamu
7
223. Development and Analysis of a Novel DOOR Endpoint for Complicated Intra-abdominal Infections (cIAI) Using 10 Registrational Trials for Antibacterial Drugs
Autor: Tori Kinamon, Ramya Gopinath, Ursula Waack, Mark Needles, Daniel Rubin, Deborah Collyar, Sarah B Doernberg, Scott R Evans, Toshimitsu Hamasaki, Thomas L Holland, Jessica Howard-Anderson, Henry Chambers, Vance G Fowler, Sumathi Nambiar, Peter Kim, Helen W Boucher
Publikováno v: Open Forum Infectious Diseases. 9
Background Desirability of outcome ranking (DOOR) uses an ordinal ranking system to evaluate global outcomes in clinical trial participants by incorporating safety and efficacy assessments into a single endpoint. In this study, we developed and appli
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d0d3ddea3f0c0f7b4962305cd76d4723
https://doi.org/10.1093/ofid/ofac492.301
Zobrazit plný text záznamu
8
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward
Autor: David E. Greenberg, Amanda Jezek, Kevin Outterson, Amila K. Nanayakkara, Vance G. Fowler, Helen W. Boucher
Publikováno v: CA: A Cancer Journal for Clinicians. 71:488-504
Infection is the second leading cause of death in patients with cancer. Loss of efficacy in antibiotics due to antibiotic resistance in bacteria is an urgent threat against the continuing success of cancer therapy. In this review, the authors focus o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e059fc2bb4b77ed1535c24a542910847
https://doi.org/10.3322/caac.21697
Zobrazit plný text záznamu
10
Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3 Randomized Trial
Autor: Michael W Dunne, Steven I Aronin, Anita F Das, Karthik Akinapelli, Michael T Zelasky, Sailaja Puttagunta, Helen W Boucher
Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Background There are limited treatment options for uncomplicated urinary tract infection (uUTI) caused by resistant pathogens. Sulopenem etzadroxil/probenecid (sulopenem) is an oral thiopenem antibiotic active against multidrug-resistant pathogens th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::393d7314055537aa4009f345fb5135b9
https://pubmed.ncbi.nlm.nih.gov/36069202
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje